Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

StatusCompleted
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv15
  2. Results first posted: May 19, 2010v14 Show 4 more changesShow less
    • Primary endpoint revised
    • Enrollment target: estimated 65 to confirmed 60
    • Start date: Apr 2006 to May 2006
    • Secondary endpoints: 4 to 3
  3. Trial status: Recruiting to Completed
    • Study sites revised (43)
    v13
  4. Study sites revised (43)v12
  5. Primary and study completion dates: Apr 2008
    • Secondary endpoints: details revised at 4 of 4 entries
    • Study arms: 0 to 3
    • Collaborators expanded, about 1 word
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 42 to 43v10
  2. Study sites: 43 to 42
    • Secondary endpoints revised (4)
    v9
  3. Primary endpoint revisedv8
  4. Secondary endpoints revised (4)
    • Primary endpoint revised
    v7
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 29 to 43
    • Start date: Aug 2006 to Apr 2006
    v6
  6. Re-verified, no change to tracked fieldsv5
  7. Start date: Apr 2006 to Aug 2006v4
  8. Start date: May 2006 to Apr 2006v3
  9. Start date: Apr 2006 to May 2006v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.
Trial Details
NCT Number NCT00300755
Lead Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators: Nycomed
Conditions
(from sponsor)		 Gastroesophageal Reflux
Related terms Gastroesophageal Reflux
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov